Abstract
Among 80 healthy persons who had received a single dose of edoxaban, the whole-blood clotting time was reduced significantly more rapidly in those who received the novel small molecule PER977 than in controls who were not given PER977.
Cite
CITATION STYLE
APA
Ansell, J. E., Bakhru, S. H., Laulicht, B. E., Steiner, S. S., Grosso, M., Brown, K., … Costin, J. C. (2014). Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban. New England Journal of Medicine, 371(22), 2141–2142. https://doi.org/10.1056/nejmc1411800
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free